| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $888K | -5.0% | — |
| SG&A Expense | $1.5M | -1.0% | +4.5% |
| Operating Income | -$2.4M | +4.7% | +7.0% |
| Pre-tax Income | -$2.4M | +7.0% | -125.0% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$2.4M | +7.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.4M | -43.5% | +1193.9% |
| Current Assets | $5.4M | -37.1% | +109.2% |
| Total Assets | $15.3M | -18.5% | +43.6% |
| Current Liabilities | $2.8M | -39.4% | -24.2% |
| Total Liabilities | $8.3M | -15.5% | -8.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.4M | — | — |
| Capital Expenditures | $214K | — | — |
| Investing Cash Flow | -$2.3M | — | — |
| Financing Cash Flow | $1.6M | — | — |
| Free Cash Flow | -$7.6M | — | — |
| -123.4% |
| EPS (Basic) | -$0.39 | +4.9% | +31.6% |
| EPS (Diluted) | -$0.39 | +4.9% | +31.6% |
| $6.9M |
| -21.8% |
| +348.3% |